Darryl Irwin News Today

/PRNewswire/ -- Agena Bioscience and nRichDX have advanced their existing technical collaboration to a commercial partnership that co-promotes their products...

Share this article Share this article SAN DIEGO, March 1, 2021 /PRNewswire/ -- Agena Bioscience®, a global provider of low-cost, high-throughput molecular testing solutions, today announced the launch of the MassARRAY® SARS-CoV-2 Variant Panel (RUO) for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and Denmark (Cluster 5) variants. The MassARRAY® technology is a benchtop system that provides timely and accurate analysis of up...